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Summary
A prominent feature of ionotropic glutamate receptors
from the AMPA and kainate subtypes is their profound
desensitization in response to glutamate—a process
thought to protect the neuron from overexcitation. In
AMPA receptors, it is well established that desensiti-
zation results from rearrangements of the interface
formed between agonist-binding domains of adjacent
subunits; however, it is unclear how this mechanism
applies to kainate receptors. Here we show that stabi-
lization of the binding domain dimer by the generation
of intermolecular disulfide bonds apparently blocked
desensitization of the kainate receptor GluR6. This
result establishes a common desensitization mecha-
nism in both AMPA and kainate receptors. Surpris-
ingly, however, surface expression of these non-
desensitizing mutants was drastically reduced and
did not depend on channel activity. Therefore, in addi-
tion to its role at the synapse, we nowpropose an intra-
cellular role for desensitization in controlling matura-
tion and trafficking of glutamate receptors.
Introduction
L-glutamate, the major excitatory neurotransmitter in
the brain, activates three distinct types of ionotropic glu-
tamate receptors (iGluRs): NMDA, AMPA, and kainate,
named after their relative sensitivity to agonists. All
iGluRs assemble as tetramers from pools of homolo-
gous subunits. Of these, subunits GluR1-4 assemble
the AMPA receptors, and subunits GluR5-7 and KA1-2
form the kainate receptors (Dingledine et al., 1999).
The subunits themselves consist of four principle do-
mains: an extracellular N-terminal domain (NTD), which
is implicated in subunit oligomerization; an extracellular
ligand-binding domain (LBD), composed of the so-
called S1 and S2 segments; a channel-forming domain,
consisting of three transmembrane domains (M1, M3,
and M4) and a reentrant loop (M2); and an intracellular
C-terminal domain (CTD), involved in receptor trafficking
and anchoring (Madden, 2002; Mayer, 2006). Currently,
structural data is available only for the LBD (Erreger
et al., 2004; Mayer et al., 2006), demonstrating the spe-
cial folding of S1 and S2 in two globular domains that
*Correspondence: yaelb@cc.huji.ac.ilbind glutamate in a cleft formed between them (see
Figure 1C).
Activation of iGluRs is followed by either deactivation
attributable to ligand unbinding or desensitization
caused by closing of the ion channel pore while the
receptor remains in a ligand-bound state. Both AMPA
and kainate receptors desensitize completely and rap-
idly in response to glutamate, with a time constant of
w5 ms (Dingledine et al., 1999). This profound desensi-
tization, together with slow recovery, is thought to play
an important role in determining the frequency and
amplitude of excitatory responses in the brain and may
provide a backup mechanism preventing excitotoxicity
during brain damage that causes an increase in gluta-
mate concentrations at the synapse (Frandsen and
Schousboe, 2003; Jones and Westbrook, 1996).
In AMPA receptors there is a strong correlation
between the extent of receptor desensitization and the
stability of the dimer interface formed between LBDs
of adjacent subunits. Key evidence for this correlation
came from a single-point mutant L-to-Y (L483Y in
GluR2) that abolished desensitization (Stern-Bach
et al., 1998) and was shown to stabilize the dimer inter-
face (Sun et al., 2002). Likewise, allosteric modulators,
such as cyclothiazide, bind in the interface and block
AMPA receptor desensitization (Jin et al., 2005; Partin
et al., 1996; Sun et al., 2002). Conversely, point muta-
tions that weaken the interaction between neighboring
LBDs greatly accelerate the desensitization (Horning
and Mayer, 2004; Sun et al., 2002). These findings,
together with previous work on conformational changes
during ligand binding (Armstrong and Gouaux, 2000), led
Sun et al. (2002) to propose the following model for
receptor activation and desensitization. According to
this model, glutamate binding induces LBD cleft clo-
sure, a movement that pulls apart the linkers connecting
the LBD to the transmembrane domains and thus opens
the channel. In the next step, the dimer interface un-
dergoes conformational rearrangements that break the
contacts between the LBDs. This uncoupling relieves
the strain on the ion channel linkers, allowing the ion
channel to close even though the agonist remains bound
with high affinity. Despite these extensive studies on
AMPA receptors, in kainate receptors a similar correla-
tion between the stability of the dimer interface and
the extent of receptor desensitization is mostly lacking.
Mutations introduced to the LBD dimer interface of
GluR6 only moderately attenuated the desensitization,
if at all, and mostly resulted in accelerated desensitiza-
tion (Fleck et al., 2003). Therefore, the role of dimer in-
terface in kainate receptor desensitization remains an
open question.
In the course of analyzing the contribution of residues
in the S2 segment to GluR6 function, we found a single
residue, K696, which, when mutated to arginine, present
in AMPA receptors, slowed the onset of desensitization
by 5-fold. Structurally, K696 projects to the dimer inter-
face and maps close to E787 from the adjacent subunit.
Mutating these sites to cysteines resulted in an apparent
block of receptor desensitization. This double-cysteine
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1038Figure 1. Interaction between Residues K696 and E787 Stabilizes the Dimer Interface of GluR6
(A and B) Superimposed normalized current traces (holding potential 260 mV) of outside-out patch recordings from HEK293 cells transiently
expressing GluR6 wt (gray) and R6(K696R) (blue). Patches were exposed to 3 mM glutamate for 500 ms (A) or 1 ms (B) as indicated above
the traces. Inset in (A) shows the current decay on a faster timescale.
(C) Ribbon presentation of side (upper panel) and top (lower panel) views of the GluR6 LBD dimeric structure in complex with domoic acid (PDB
1YAE; monomers b and d). In each monomer, S1 is colored pink and S2 is cyan. The dimer interface is marked by a dotted line. The relative po-
sitioning of domains 1 and 2 and the connections to the N-terminus and the transmembrane domains (TMs) are labeled. The agonist domoic acid
(DA; black) and the residues K696 (blue) and E787 (red) are shown as spheres. Helixes D, F, and J are highlighted by a cartoon presentation. The
position of residue Y521, which corresponds to the L-to-Y mutation in AMPA receptors, and the interacting residue L783 are marked by asterisks
on helixes D and J, respectively. Figure was created by PyMOL (http://pymol.sourceforge.net).
(D) Bar plot showing the desensitization time constant (t) of GluR6 wt (gray bar) and various point mutations at positions K696 (blue bars), E787
(red bars), or both (black bars). Bars are the mean6 SEM of 3 to 24 patches. The statistical significance (**p < 0.01, ***p < 0.001) between GluR6
wt and each mutant was determined using t test and one-way ANOVA. Mutants for which no currents could be recorded from more than
20 patches are marked by ‘‘no current.’’mutation also slowed the deactivation rate and in-
creased agonist efficacy, a phenotype resembling the
behavior of the L-to-Y mutation in the AMPA receptors.
These results demonstrate that the dimer interface is
a pivotal participant in the mechanism of kainate recep-
tor desensitization as well. Surprisingly, however, sur-
face expression of this nondesensitizing mutant was
drastically reduced and did not depend on channel
activity. Therefore, in addition to its role at the synapse,
we suggest that the desensitization state is a key check-
point recognized by the ER quality-control machinery to
ensure that only receptors that can desensitize will
reach the cell surface.
Results and Discussion
Mutations at a Putative Intersubunit Pair, K696
and E787, in GluR6 Alter Receptor Kinetics
Similar to previous studies (Fleck et al., 2003; Swanson
et al., 1997), we looked for subtype-specific residues
that control biophysical properties of the kainate recep-
tor GluR6. Receptors were expressed in HEK293 cells,
and channel kinetics was determined using patch-
clamp recordings combined with rapid solution
exchange. As shown in Figure 1A, GluR6 wild-type (wt)receptors completely and rapidly desensitized in
response to a prolonged application of saturating gluta-
mate (3 mM for 500 ms) with a desensitization time
constant (tdes) of 4.4 6 0.1 ms (n = 24; Figure 1D), in
agreement with published data (Dingledine et al.,
1999). In the course of screening residues in the S2 seg-
ment, we found that substitution of K696, a conserved
residue in GluR5/6/7, with the equivalent arginine, pres-
ent in all AMPA receptor subunits, slowed the onset of
GluR6 desensitization by approximately 5-fold (K696R,
tdes = 20.2 6 0.9 ms, n = 12; Figures 1A and 1D). The
K696R mutation also slowed the rate of channel closure
in response to a brief application of glutamate (1 ms;
Figure 1B), presenting a deactivation time constant
(tdea) of 9.8 6 0.3 ms (n = 8) compared to 2.3 6
0.3 ms (n = 7) measured for GluR6 wt receptors. In con-
trast to the profound effects on the desensitization and
deactivation rates, the K696R mutation had no signifi-
cant effect on the rate of recovery from desensitization
(data not shown).
Structurally, K696, which maps to the end of helix F of
the LBD (Mayer, 2005; Nanao et al., 2005), seems to pro-
ject to the dimer interface and may interact with E787
from the adjacent subunit, a residue located at the end
of helix J (Figure 1C). E787 is conserved across all
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ing residue, E755, in the AMPA receptor subunit GluR2
is proposed to be part of a hydrogen-bond network
that connects the base and middle of helix J of one
subunit with helix D of the adjacent subunit (Horning
and Mayer, 2004). We hypothesized that, in GluR6, the
K696R mutation stabilizes the dimer interface by inter-
acting with E787, thus accounting for the attenuation
in receptor kinetics. Indeed, mutation of E787 to alanine
(E-A), predicted to break the interaction between K696
and E787, was found to accelerate the onset of GluR6
desensitization (Figure 1D). Mutation of E787 to gluta-
mine (E-Q) resulted in no detectable currents (n > 20
patches), but when combined with the K696R mutation,
we observed small-current amplitudes with faster
desensitization (K-R/E-Q, Figure 1D). Likewise, when
combined, the K696R mutation attenuated the effect of
E787A, exhibiting desensitization kinetics like GluR6
wt (K-R/E-A; Figure 1D). Based on these observations,
we expected that mutation of K696 to alanine would ac-
celerate the desensitization as observed for R6(E787A).
However, instead we observed a reduced desensitiza-
tion rate similar to the K696R mutation (Figure 1D).
A similar reduced rate was also observed for K696
mutation to glutamate (K-E) or methionine (K-M), but
not when mutated to phenylalanine (K-F), tyrosine
(K-Y), or tryptophan (K-W), which exhibited GluR6 wt
kinetics (Figure 1D). Although these results may not
support a direct interaction between K696 and E787,
the bidirectional kinetic effects of mutations at these
positions support the hypothesis that the stability of
the dimer interface is an important determinant of
kainate receptor desensitization.
To further establish a correlation between dimer inter-
face stability and the extent of desensitization, we
attempted to generate a nondesensitizing receptor by
restricting dimer movement. Due to the short distance
between K696 and E787, we predicted that mutating
these residues to cysteines would generate an inter-
subunit disulfide bond, thereby locking the dimer con-
formation. However, no currents could be recorded from
the double-cysteine mutant R6(K696C/E787C) (n > 50
patches). The single-cysteine mutant R6(K696C)
exhibited current amplitudes compatible to GluR6 wt,
with a moderate shift of the desensitization rate (tdes =
7.2 6 0.3 n = 5 p < 0.01; Figure 1D), while no currents
could be recorded from cells expressing the R6(E787C)
mutant (n > 20 patches).
Block of GluR6 Desensitization by the
Double-Cysteine Mutation K696C/E787C
Establishes a Common Desensitization
Mechanism in Kainate and AMPA Receptors
In parallel to the experiments in HEK293 cells, we
expressed the various mutants in Xenopus oocytes,
and the extent of GluR6 receptor desensitization was
estimated by measuring whole-cell currents before
and after treatment with concanavalin A (ConA), a desen-
sitization blocker of kainate receptors (Mayer and
Vyklicky, 1989; Partin et al., 1993). As seen in Figure 2,
application of glutamate for 2 s to oocytes expressing
GluR6 wt receptors evoked only small currents (3–10
nA), if at all, reflecting the fast and complete desensitiza-
tion of these receptors. However, after blocking thedesensitization with ConA, robust steady-state currents
(2–4 mA) were observed. The R6(K696R), in which the
desensitization rate is w5-fold slower (Figure 1), ex-
hibited a brief response to glutamate, which comprised
w15% of the steady-state current recorded with ConA
(Figure 2A). The single-cysteine mutant R6(K696C)
behaved like GluR6 wt, while no currents could be
recorded from oocytes expressing the counterpart
mutant R6(E787C) even after treatment with ConA
(Figure 2A). These results are similar to what we
observed in the HEK293 cells. Surprisingly, however, in
contrast to the apparent loss of function in the HEK293
cells, glutamate evoked high steady-state currents in
oocytes expressing the double-cysteine mutant
R6(K696C/E787C), which were not further affected by
ConA. This result suggested that desensitization in this
mutant is apparently blocked, as we initially predicted.
In addition, we observed that, upon removal of gluta-
mate, the duration of current return to baseline was 3-
to 5-fold longer than that observed for GluR6 wt or for
the mutants R6(K696R) and R6(K696C) (Figure 2A,
note the timescale). In support of intersubunit connec-
tion between K696C and E787C in creating the non-
desensitized phenotype, high steady-state currents
were recorded from oocytes coexpressing the single-
cysteine mutants, R6(K696C) and R6(E787C). This
steady-state current comprised w30% of the currents
recorded after ConA treatment, reflecting the mixed
population of desensitizing and nondesensitizing re-
ceptors. To further support the idea that the double-
cysteine mutant R6(K696C/E787C) generates nonde-
sensitizing current in the absence of ConA, we recorded
excised patches from oocytes and subjected them to
fast perfusion. Similar to HEK293 cells, rapid glutamate
application to patches excised from GluR6 wt induced
fast desensitizing responses. However, the same appli-
cation to patches excised from oocytes expressing the
double-cysteine mutant resulted in completely nonde-
sensitizing currents (Figure 2B). Western blot analysis
under nonreducing conditions further confirmed the
formation of a disulfide bond between the introduced
cysteines in R6(K696C/E787C), but not in GluR6 wt or
in the single-cysteine mutants (Figure 2C). Taken
together, these results support our conclusion that sta-
bilization of the dimer interface leads to desensitization
block, as seen for the L-to-Y mutation in AMPA recep-
tors (Stern-Bach et al., 1998; Sun et al., 2002).
The L-to-Y mutation in AMPA receptors does not only
block desensitization and slow deactivation (Robert
et al., 2001; Stern-Bach et al., 1998; Sun et al., 2002), it
also increases agonist apparent affinity (Holm et al.,
2005; Stern-Bach et al., 1998). Therefore, we wanted to
test whether our double-cysteine mutation also has an
effect on agonist apparent affinity. We thus measured
EC50 values for glutamate and kainate (Figure 2D). For
both agonists, R6(K696C/E787C) showed w15-fold in-
creased apparent affinity as compared to GluR6 wt.
A significant shift was also observed for R6(K696R)
(5-fold, p < 0.001), in which the desensitization rate is
5-fold slower (Figure 1), but not for R6(K696C) (data
not shown). Because K696 resides on helix F, which
contains residues important for agonist binding and sta-
bilization of the intradomain closed-cleft conformation
(Armstrong and Gouaux, 2000; Mayer, 2005; Mayer
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K696C/E787C Blocks GluR6 Desensitization
in Xenopus Oocytes
(A) Two electrode voltage-clamp recordings
from Xenopus oocytes at holding potential
of 270 mV. Current traces before and after
treatment with the desensitization blocker
concanavalin A (+ConA) are shown for the
homomeric expression of GluR6 wt, K696R
(K-R), K696C (K-C), E787C (E-C), and
R6(K696C/E787C) (K-C/E-C), and for the
coexpression of K696C and E787C (K-C +
E-C). In each case, oocytes were exposed
for 2 s to 1 mM glutamate, except for the
double-cysteine mutant K-C/E-C, which was
exposed to 30 mM glutamate. After 2 min
wash, the oocytes were treated with ConA
(1 mg/ml) for 5 min, washed for 2 min, and
then re-exposed to glutamate for 2 s. The
time course of each glutamate application is
indicated by a black bar above the corre-
sponding trace.
(B) Recordings from excised outside-out
patches pulled from Xenopus oocytes
expressing GluR6 wt or the double-cysteine
mutant (K-C/E-C) demonstrate the lack of
receptor desensitization in the mutant on
a fast timescale.
(C) Western blot analysis (4%–12% gradient
SDS-PAGE) under nonreducing (2DTT) and
reducing (+DTT) conditions demonstrates
the formation of a disulfide bond across the
dimer interface in the K-C/E-C mutant.
(D) Left and middle panels show dose-
response measurements for glutamate and
kainate, respectively, on GluR6 (wt; square),
R6(K696R) (K-R; circle), and R6(K696C/
E787C) (K-C/E-C; triangle). Responses to different concentrations of agonist (I) were normalized to the maximum response obtained at 1 mM
glutamate and 0.1 mM kainate, respectively, and fitted with Hill equation. Right panel shows dose-inhibition curve for the competitive antagonist
NBQX on GluR6 (wt; square) and R6(K696C/E787C) (K-C/E-C; triangle). Responses (I) to different concentrations of NBQX in the presence of
either 30 mM glutamate for GluR6 or 2 mM glutamate for R6(K696C/E787C) were normalized to the glutamate response without NBQX (I0) and
fitted with Hill equation. Each point in the different panels is the mean 6 SEM of six to eight oocytes. Glutamate EC50 values (mM): 18 6 1
(wt), 3.5 6 0.3 (K-R), and 1.24 6 0.07 (K-C/E-C). Kainate EC50 values (mM): 1.7 6 0.1 (wt), 0.32 6 0.04 (K-R), and 0.11 6 0.01 (K-C/E-C). NBQX
IC50 values (mM): 3.9 6 0.1 (wt) and 3.9 6 0.2 (K-C/E-C).et al., 2006; Nanao et al., 2005; Weston et al., 2006a), it
was important to determine whether the change in ago-
nist apparent affinity is due to a change in agonist bind-
ing affinity or a change in efficacy (i.e., the coupling effi-
ciency between agonist binding and channel opening).
To distinguish between these two possibilities, we
determined the IC50 values of the competitive antago-
nists NBQX (Figure 2D) and kynurenic acid (data not
shown). No change in IC50 was observed for either
antagonist, implying that the increase in agonist appar-
ent affinity is a result of increased efficacy.
Overall, the phenotype of the double-cysteine mutant
in Xenopus oocytes, i.e., lack of desensitization, re-
duced deactivation, and increased efficacy, resembles
the phenotype of the L-to-Y mutation in AMPA receptors
(Robert et al., 2001; Stern-Bach et al., 1998; Sun et al.,
2002) and the behavior of AMPA receptor-positive allo-
steric modulators (Jin et al., 2005; Partin et al., 1996;
Sun et al., 2002), shown to stabilize the dimer interface.
Therefore, we can conclude that, like in AMPA recep-
tors, the stability of the dimer interface is a key determi-
nant in kainate receptor gating as well. During revision of
the present manuscript, a paper appeared (Zhang et al.,2006) showing results entirely compatible with our inter-
pretation.
Block of GluR6 Desensitization Impairs
Receptor Trafficking
The observation that the double-cysteine mutant
R6(K696C/E787C) was functional in Xenopus oocytes
while no currents could be detected in HEK293 cells
suggests that cell-surface expression of this mutant in
the HEK293 cells may be impaired. Indeed, confocal
microscopy imaging on receptors tagged with EGFP at
their N-termini revealed that, unlike GluR6 wt, which is
targeted to the cell membrane, R6(K696C/E787C) is
retained inside the cell, mostly around the nucleus
(Figure 3A). To quantify surface expression, we per-
formed ELISA assays using either HA- or EGFP-tagged
receptors, and surface expression was determined as
the ratio of immunological labeling of nonpermeable
and permeable cells. As seen in Figure 3B, surface
expression similar to that of GluR6 wt was observed
for the active R6(K696R) and R6(K696C), as well as for
the apparent inactive R6(E787C). In contrast, surface
expression of the double-cysteine mutant R6(K696C/
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Membrane Trafficking of GluR6 in HEK293
Cells
(A) Confocal microscopy imaging of HEK293
cells expressing EGFP-tagged GluR6 wt or
the double-cysteine mutant R6(K696C/
E787C) (K-C/E-C; the lower panels are inset
magnifications). In both cases, pictures rep-
resent single confocal sections illustrating
GFP fluorescence without (left) and with the
transmitted light image (right). Note that while
the GluR6 wt is targeted to the cell mem-
brane, the K-C/E-C mutant is sequestered
at the ER, giving fluorescence mainly around
the nucleus and far from the membrane.
(B) Bar plot of cell-surface ELISA assays done
on HEK293 cells expressing HA-tagged (light
gray bars) or EGFP-tagged (dark gray bars)
constructs. Proteins were detected using
HA or EGFP antibodies, and the percentage
of surface protein expression (% Surface)
was determined as the absorbance ratio of
nonpermeable and permeable cells as de-
scribed in Experimental Procedures. Bars
are mean6 SEM of three to four experiments
done in duplicate.
(C) Receptor maturation state determined
by sensitivity to endoglycosidase H (EndoH).
Triton X-100 extracts from HEK293 cells
expressing HA-tagged constructs were sub-
ject to EndoH treatment to cleave immature
glycosylation. The level of fully deglycosy-
lated proteins was determined by treatment
with peptide-N-glycosidase F (PNGase). Filled arrowhead denotes maturely glycosylated receptors (m); the empty arrowhead, immature (i). Blots
were probed with C-terminal GluR6 antibodies. Shown are representative blots of at least three separate experiments.
(D) Bar plot of cell-surface ELISA on EGFP-tagged constructs performed as described in (B).E787C) was drastically reduced. Previous studies have
shown that mutant kainate receptor subunits incapable
of binding glutamate do not traffic to the cell surface
(Mah et al., 2005; Valluru et al., 2005). We therefore com-
pared the surface expression of the double-cysteine
mutant to that of R6(R523K), a mutant which is both de-
fective in glutamate binding and trafficking (Mah et al.,
2005). As seen in Figure 3B, levels of surface expression
were similar for both R6(R523K) and R6(K696C/E787C)
mutants.
To further examine receptor trafficking, we analyzed
the glycosilation state of these mutants by treatment
with endoglycosidase H (EndoH) and peptide-N-glyco-
sidase F (PNGase). EndoH specifically cleaves high-
mannose-type sugars characteristic of ER resident
proteins. High-mannose-type sugars are further pro-
cessed in the Golgi, and most glycoproteins acquire
EndoH resistance. Sensitivity to EndoH therefore re-
flects the protein maturation state. PNGase, on the other
hand, cleaves all N-linked glycans and thus serves as
a control for full N-linked deglycosylation. As seen in
Figure 3C, the majority of GluR6 wt and R6(K696R)
protein is resistant to EndoH (left panels), consistent
with the confocal microscopy and the cell-surface
ELISA data (Figures 3A and 3B). In contrast, no En-
doH-resistant fraction could be observed in R6(K696C/
E787C) (bottom right panel) as well as in R6(R523K),
which lacks functional glutamate binding (top right
panel; Mah et al., 2005). Altogether, these results
suggest that the nondesensitizing mutant was retainedin the ER. To check that the nondesensitizing receptors
are also retained in neurons, we expressed the EGFP-
tagged GluR6 wt and R6(K696C/E787C) in cultured
hippocampal neurons and included as a control the
binding-site mutant R6(R523K). Total protein expres-
sion was detected by the GFP fluorescence intensity,
and surface expression was determined by exposing
the live neurons to anti-GFP antibody. As seen in
Figure 4, GluR6 wt was targeted to the membrane, while
no surface labeling was observed for either of these two
mutants.
It could be argued that the apparent impaired matura-
tion and cell-surface expression of R6(K696C/E787C)
may be caused by cell toxicity. Ion flux in response to
traces of glutamate in the tissue culture media may
cause cell death due to the block of receptor desensiti-
zation. This could then result in selection for cells with
immature receptors. To test this possibility, we com-
bined the nondesensitizing mutation with a mutation in
the channel pore, M610R, shown to impair channel
permeation (Robert et al., 2002). Expression of the
M610R-containing mutants in Xenopus oocytes con-
firmed the lack of channel activity (data not shown).
ELISA assays on HEK293 cells demonstrated that, while
R6(M610R) trafficked to the cell surface like GluR6 wt,
the triple-mutant R6(M610R/K696C/E787C) did not
(Figure 3D). In addition, incubation of cells transfected
with R6(K696C/E787C) with the competitive antagonists
NBQX or kynurenic acid did not rescue cell-surface
expression (data not shown). Finally, no apparent
Neuron
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using an in vitro toxicology assay kit based on lactic de-
hydrogenase (Tox-7, Sigma; data not shown). These re-
sults thus exclude cell toxicity as the cause of the appar-
ent impaired trafficking of the nondesensitizing mutant.
The observation that trafficking of the double-
cysteine mutant R6(K696C/E787C) in the HEK293 cells
was impaired led us to investigate the trafficking in
Xenopus oocytes, where high activity was observed
(Figure 2). Oocytes were injected with GluR6 wt and
the various cysteine mutants. Whole-cell current ampli-
Figure 4. The Nondesensitizing Mutant R6(K696C/E787C) Does Not
Traffic to the Membrane in Cultured Hippocampal Neurons
GFP-tagged GluR6 receptors were transfected in cultured hippo-
campal neurons. Neurons were incubated in vivo with chicken
anti-GFP antibody to label receptors present at the surface, followed
by Alexa 647-conjugated goat anti-chicken secondary antibody.
Panels show total receptor expression visualized as the GFP fluo-
rescence (green), while surface receptors are in red. GluR6 wt (A)
traffics to the neuronal membrane. Top panels are average projec-
tions of ten confocal sections. The bottom inserts are single confo-
cal sections detailed from separate neurons at the level of neuronal
body (left) and a dendrite (right). The binding-site R523K mutant (B)
and the nondesensitizing K-C/E-C mutant (C), expressed abun-
dantly (left) but were not detected in the membrane, as judged by
the lack of signal in the red channel (right). The examples correspond
to a single confocal section taken approximately at the equator of
the cell body (B) and an average projection (C).tudes and cell-surface expression (measured by cell-
surface biotinylation) were determined in parallel. As
we observed before, in the presence of ConA, compara-
ble current amplitudes were recorded from GluR6 wt,
the single-cysteine mutant R6(K696C) and the double-
cysteine mutant R6(K696C/E787C), while no currents
were observed for the single-cysteine mutant
R6(E787C) (Figure 5A). In contrast, both single-cysteine
mutants R6(K696C) and R6(E787C) showed relatively
high surface expression (95% and 60%, respectively,
measured as the ratio between biotinylated to total
protein fraction and normalized to GluR6 wt), while
the double-cysteine mutant R6(K696C/E787C) did not
(15%). The highly attenuated surface expression of
R6(K696C/E787C) was confirmed by the EndoH sensi-
tivity assay (Figure 5B). The relative low surface expres-
sion of R6(K696C/E787C), while still retaining high activ-
ity comparable to GluR6 wt, is consistent with its
increased agonist efficacy (Figure 2D). Taken together,
the impaired trafficking of the nondesensitizing mutant
in both heterologous cell types and in neurons suggests
that the desensitization status of the fully assembled
receptor is subject to a quality-control screen in the ER.
To further establish a correlation between block of
receptor desensitization and ER retention, we looked
Figure 5. The Double-Cysteine Mutation K696C/E787C Reduces
Membrane Trafficking in Xenopus Oocytes
(A) Relation between current amplitude and protein surface expres-
sion of different constructs expressed in Xenopus oocytes. Bar plot
shows the mean 6 SEM (n = 10 oocytes) of whole-cell currents
recorded before (black bars) and after (gray bars) treatment with
ConA as described in Figure 2A. Twenty oocytes from the same in-
jection were subjected in parallel to surface biotinylation analysis.
Blots of biotinylated (upper panels) and total (lower panels) protein
fractions were probed with C-terminal GluR6 antibodies. Bands
were quantified with ImageJ; ‘‘% surface’’ reflects the level of bioti-
nylated fraction from the total, normalized to GluR6 wt.
(B) Receptor maturation state measured by EndoH and PNGase di-
gestion on extracts of oocytes expressing GluR6 (wt) or R6(K696C/
E787C) (K-C/E-C). Western-blots were probed as described in
Figure 3C. Filled arrowhead denotes mature receptors (m); empty
arrowhead, immature (i).
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a cross-dimer disulfide bond. Based on the GluR6 LBD
crystal (Mayer, 2005; Nanao et al., 2005), we noticed
that Y521, corresponding to the nondesensitizing
L-to-Y mutation in AMPARs, is positioned close to
L783 of the second monomer (Figure 1C, asterisks).
Therefore, we mutated these sites to cysteines. When
expressed in Xenopus oocytes, this double-cysteine
mutant, R6(Y521C/L783C), also exhibited high steady-
state currents in response to glutamate, which were
only moderately (21%6 5%, n = 7) increased after treat-
ment with ConA (Figure 6A, left). This is consistent with
an apparent block of desensitization due to stabilization
of the dimer interface by the formation of a disulfide
bond between the introduced cysteines (Figure 6A,
right). This mutant was also entirely retained in
HEK293 cells as indicated by a complete sensitivity to
EndoH deglycosilation (Figure 6B).
The Desensitized Conformation Is a Key Quality
Checkpoint for Glutamate Receptor Trafficking
It is now established that in the ER multimeric proteins
are subject to a resident quality-control system, which
verifies that the proteins are properly folded and assem-
bled before export to Golgi compartments and presen-
tation on the cell surface (Ellgaard and Helenius, 2003;
Kleizen and Braakman, 2004; Trombetta and Parodi,
2003). In ionotropic glutamate receptors, subunit
assembly masks ER retention signals, especially in het-
Figure 6. Generation of a Cross-Dimer Disulfide Bond between Res-
idues Y521 and L783 Blocks Receptor Desensitization and Traffick-
ing to the Membrane
(A) Left, whole-cell recordings from oocytes expressing the double-
cysteine mutant R6(Y521C/L783C) (see asterisks in Figure 1C),
before and after treatment with ConA done as described in
Figure 2A; right, Western blot analysis on oocytes’ homogenates un-
der reducing and nonreducing conditions shows the formation of
a disulfide bond in the double-cysteine mutant Y-C/L-C, but not in
GluR6 wt or in the trafficking arrest binding-site mutant R523K.
(B) EndoH-resistant assay on HEK293 cells, done as described in
Figure 3C, shows complete lack of receptor maturation of the Y-C/
L-C mutant, consistent with lack of surface expression.eromeric assemblies that make the majority of native
receptors (Isaac et al., 2004; Lerma, 2006; Pinheiro and
Mulle, 2006; Vandenberghe and Bredt, 2004). For exam-
ple, the kainate receptor KA2 subunit contains retention
signals in the intracellular C-tail and the loop preceding
M3, which prevent ER export unless it assembles with
the GluR6 subunit (Nasu-Nishimura et al., 2006; Ren
et al., 2003; Yan et al., 2004). Similarly, in AMPA recep-
tors the Q/R site in the pore-forming re-entrant loop is
proposed to act as a retention signal that ensures the
incorporation of GluR2 R-edited forms in heteromeric
assemblies with other AMPA receptor subunits (Greger
et al., 2002, 2003).
In addition to proper assembly, recent studies sug-
gest that receptor functionality may also be monitored,
because mutations that eliminate glutamate binding in
both AMPA and kainate receptor subunits promote
retention of these receptors (Grunwald and Kaplan,
2003; Mah et al., 2005; Valluru et al., 2005). Our results
with both the K696C/E787C and Y521C/L783C muta-
tions in GluR6, shown to block desensitization and
reduce surface expression, demonstrate that the recep-
tor desensitization status is also monitored by the
quality-control machinery. This phenomenon is not
unique to kainate receptors. Recently, it has been
shown that the nondesensitizing L-to-Y mutation in the
AMPA receptor GluR2 also leads to ER retention in neu-
rons (Greger et al., 2006). Because these nondesensitiz-
ing mutants can bind glutamate, we further suggest that
glutamate binding in the ER is needed for the presen-
tation of the desensitized conformation to the quality-
control machinery. Moreover, based on the observation
that a mutation that blocks ion flow (M610R) not only did
not abolish GluR6 trafficking to the cell surface but also
did not rescue trafficking of the nondesensitizing recep-
tors (Figure 3D), we also suggest that this quality-control
machinery recognizes structural signals in the LBD
rather than monitoring channel activity. It is yet to be de-
termined whether this machinery recognizes a specific
trafficking motif, exposed or masked at the desensitized
state, or monitors the global conformation of the recep-
tor. However, only receptors that achieve the desensi-
tized conformation will be exported to the cell surface
(see Figure 7 for illustrative model). Finally, in contrast
to the K696C/E787C and Y521C/L783C mutations, sur-
face expression of the R6(K696R) mutant in which
desensitization is 5-fold slower (Figure 1) was similar
to GluR6 wt (Figures 3). This result, however, does not
contradict our model because even though desensitiza-
tion is significantly slowed, the R6(K696R) mutant is fully
converted to the desensitized state due to the continu-
ous presence of glutamate in the ER (Meeker et al.,
1989). A similar argument can be provided for the
GluR6 interface point mutant K531G (Fleck et al., 2003)
and the quadruple mutant R6(K525E/K696R/I780L/
Q784K) (Zhang et al., 2006), which although exhibiting
slow desensitization, nevertheless undergo desensitiza-
tion, thus surface expression seems normal. In fact,
Greger et al. (2006) showed that the unedited GluR2 at
the R/G and flip/flop sites (R-flip), which is less desensi-
tized than the fully edited form (G-flop) assembles and
traffics to a greater extent, a phenomenon attributed to
a greater stability of the dimer interface in promoting
receptor tetramerization (Greger et al., 2006). Due to
Neuron
1044the highly efficient trafficking of GluR6 wt, we could not
determine whether a similar phenomenon occurs with
our R6(K696R) mutant.
In conclusion, numerous studies have implicated the
activation of both AMPA and kainate receptors in neuro-
nal damage, a process known as glutamate excitotoxic-
ity, which plays a prominent role in both acute (e.g.,
ischemia) and chronic (e.g., Alzheimer’s, ALS, Parkin-
son’s) neurodegenerative disorders (Choi, 1992; Frand-
sen and Schousboe, 2003; Lerma, 2006; Pinheiro and
Mulle, 2006). The fast and profound desensitization of
these receptors is thus thought to provide a natural neu-
roprotective mechanism. Given its importance at the
synapse, here we show that the desensitization state
is a key checkpoint recognized by the ER quality-control
machinery to ensure that only properly working recep-
tors will reach the cell surface.
While this paper was under final review, a paper by
Weston et al. (2006b) appeared, which confirms our ob-
servation that stabilization of the binding domain dimer
interface by disulfide cross-links blocks kainate recep-
tor desensitization.
Figure 7. Model of Trafficking Constrains on Glutamate Receptors
The cartoon shows two subunits forming one of the two dimers that
assemble an active glutamate receptor. For each subunit, the LBD is
shown as two dark gray bars, which correspond to domains 1 and 2.
Domain 2 is connected via short linkers (black line) to the channel-
forming transmembrane domains, shown as a light gray box.
Following is the intracellular CTD drawn as a gray line (the extracel-
lular NTD is omitted). Receptor assembly occurs in the ER (a) and
involves masking of retention signals in the CTD and/or the channel
domain (marked by asterisks). Glutamate (black circle) binding to
the receptor shifts its conformation to the open nondesensitized
mode (a to b), which quickly converts to the desensitized state
(b to c). Only the latter form is able to traffic to the cell surface
(c to d). On the surface, glutamate unbinds (d to e), and the receptor
is ready to receive a synaptic input. It is also possible that the un-
bound-resting conformation is restored in the post-ER secretory
compartments (c to e). Receptors unable to bind glutamate, like
the R6(R523K) mutant (represented by form a), are arrested and can-
not traffic to the next compartment. Receptors that can bind gluta-
mate but cannot desensitize, like the R6(K696C/E787C) mutant (rep-
resented by form b), are also trapped. Therefore, glutamate binding
in the ER is needed for the presentation of the desensitized confor-
mation to the quality-control machinery.Experimental Procedures
Molecular Biology
GluR6 (VCQ) was tagged with EGFP at the N-terminus between res-
idues 32 and 33 in pRK5. Amino acid residues are numbered relative
to the initiation methionine. Hemaglutinin (HA) tag was inserted at
the same place as EGFP using overlap extension PCR. The presence
of either tag had no effect on GluR6 kinetics. Point mutations were
made using overlap extension PCR and verified by sequencing
throughout the amplified cassette. For expression in Xenopus
oocytes, plasmids were linearized with Avr II or Asp 718 and capped
cRNA was transcribed in vitro with SP6 RNA polymerase (mMes-
sage mMachine; Ambion, Austin, TX). The quality of transcripts
was assessed by agarose gel electrophoresis and ethidium bromide
staining, and the yield was determined using NanoDrop Spectro-
photometer (Nanodrop Technology, Wilmington, DE).
HEK293 Cell Culture and Transfection
Human embryo kidney 293 (HEK293) cells were grown in DMEM
(Sigma; St. Louis, MO) supplemented with 10% FCS, 100 unit/ml
penicillin, 0.1 mg/ml streptomycin, and 1 mM sodium pyruvate (Bio-
logical Industries; Beit-Haemek, Israel) at 37C and 5% CO2. Cells
were passed twice a week until pass #20. Transfections were
made using the calcium phosphate method, Polyfect (QIAGEN, Hil-
den, Germany), or Lipofectamine 2000 (Invitrogen; San Diego, CA).
For electrophysiology recordings or confocal microscopy imaging,
cells were replated 24 hr after transfection on coverslips coated
with poly-D-lysine (0.1 mg/ml; Sigma).
HEK293 Cell Patch-Clamp Recordings
Recordings on HEK293 cells were carried out 36–48 hr after trans-
fection. Membrane currents were recorded at a given membrane
potential under the outside-out configuration of the patch-clamp
technique using the Axopatch 200B amplifier (Axon Instruments,
Foster City, CA) as described previously (Priel et al., 2005). Briefly,
membrane currents were digitized online using a Digidata 1322A in-
terface board and pCLAMP 8.2 software (Axon Instruments). Sam-
pling frequency was set to 10 kHz, and the low-pass filter was set
to 2 kHz. Patch electrodes were fabricated from borosilicate glass
with a resistance of 2–4 MU. The extracellular solution contained
(mM): 150 NaCl, 2.8 KCl, 0.5 MgCl2, 2 CaCl2, 10 HEPES, adjusted
to pH 7.4 with NaOH. The pipette solution contained (mM):
110 CsF, 30 CsCl, 4 NaCl, 0.5 CaCl2, 10 EGTA, 10 HEPES, adjusted
to pH 7.2 with CsOH. For the rapid application of glutamate, solu-
tions were applied from a double-barrel glass (theta tube) mounted
on a piezoelectric translator (Burleigh, Fishers, NY). We estimated
the speed of solution exchange by recording the open tip potentials
with solutions of different ionic strengths after expelling the patch
from the electrode. The 10%–90% solution exchange was typically
<500 ms. Data were analyzed using pCLAMP 8.2 software (Axon
Instruments) and Origin 6.1 (Origin Lab Corp., Northampton, MA).
Oocyte Preparation, Electrophysiology,
and Western Blot Analysis
Stage V–VI Xenopus laevis oocytes were prepared as previously de-
scribed (Stern-Bach et al., 1994). Oocytes were injected up to 24 hr
after isolation with 0.5–5 ng cRNA or 0.2–1 ng cDNA per oocyte, and
assayed 1–5 days later. Two electrode voltage-clamp recordings
were carried out at room temperature (RT) using GeneClamp500
connected to digidata1322A and pCLAMP8.2 (Axon Instruments).
Electrodes (Sutter Instruments, Novato, CA) were filled with 3 M
KCl and had resistance of 0.5–1 MU. Oocytes were continuously per-
fused with normal frog ringer (NFR) solution containing (mM):
10 HEPES, pH 7.4, 115 NaCl, 2.5 KCl, 1.8 CaCl2, and 0.1 MgCl2. In ex-
periments where desensitization was blocked, clamped oocytes
were incubated with concanavaline A (ConA; Sigma) at 1 mg/ml for
5–10 min before recording. For outside-out patch recordings, the
oocytes were incubated for 5–10 min in hypertonic solution (contain-
ing in mM: 40 HEPES, pH 7, 60 KCl, 10 EGTA, 8 MgCl2, and 250 su-
crose), and the vitelline membrane was removed using forceps. The
extracellular solution was NFR, and the pipette solution was as de-
scribed for the HEK293 cells. Recordings sampling, filtering, and so-
lution exchange were as describe for the HEK293 cells. Data were
analyzed using pCLAMP 8.2 and ORIGIN 6.1 software (Origin Lab
Desensitization Controls Kainate Receptor Traffic
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curves were analyzed using ORIGIN 6.1 software (Origin Lab
Corp.). For Western-blot analysis under nonreducing conditions,
oocytes (10 to 15 per construct) were homogenized with 200 ml lysis
buffer containing (mM): 100 NaCl, 100 Tris-Cl, pH 8, 0.5% Triton
X-100, and protease inhibitor cocktail (Complete Protease Inhibi-
tors, Roche). The homogenates were incubated on ice for 15 min,
centrifuged twice for 10 min at 13000 3 g, and the soluble fraction
was removed each time to a clean tube. After the second centrifuga-
tion, 20 mM NEM was added to the soluble fractions, and centrifuga-
tion was repeated twice. Sample buffer containing 63 mM Tris-Cl, pH
6.8, 10% glycerol, 2% SDS, and 0.0025% Bromophenol Blue was
added to the homogenate with 50 mM DTT (reduced sample) or with-
out DTT (nonreduced sample). Samples were subject to SDS-PAGE
using 4%–12% Tris-glycine gels (Invitrogen) and electroblotted onto
nitrocellulose membranes. Blots were incubated with C-terminal
anti-GluR6 antibodies (1:2500 dilution; Upstate Biotechnology,
Lake Placid, NY) for 1 hr at room temperature, washed, and incu-
bated for additional 1 hr with horseradish peroxidase-conjugated
goat anti-rabbit IgG (1:20,000 dilution; Jackson laboratories). Blots
were visualized by the chemiluminescence protocol, scanned, and
quantified using ImageJ software.
Immunocytochemistry and Surface Labeling of Transfected
Neurons
Live cultured hippocampal neurons were prepared using a protocol
described elsewhere (Selak et al., 2006). Neurons were transfected
at DIV10 with 1 mg of EGFP-tagged GluR6 wt, R6(R523K), or
R6(K696C/E787C) using Lipofectamine 2000, according to the man-
ufacturer’s instructions. Forty-eight hours later, neurons were
washed once with a Ringer buffer containing (mM): 160 NaCl, 15 glu-
cose, 10 HEPES, 2.5 KCl, 1.8 CaCl2, and 1 MgCl2. Neurons were in-
cubated for 1 hr at 16C with chicken anti-GFP antibody (Aves Labs,
Tigard, OR) diluted 1:1000 in the Ringer buffer supplemented with
5% normal goat serum (NGS) and containing 30 mM CNQX and
100 mM D-AP5 to prevent receptor activation. Following the incuba-
tion, neurons were washed two times with Ringer buffer and imme-
diately fixed with 4% paraformaldehyde/10% sucrose for 10 min at
room temperature. After the fixation step, neurons were washed
with PBS and then incubated for 2 hr with Alexa 647-conjugated
goat anti-chicken secondary antibody (Molecular Probes/Invitro-
gen) diluted in PBS containing 2% NGS. Neurons were then washed
2 3 5 min with PBS buffer, mounted onto slides in DAPI-supple-
mented mounting medium (Vectashield: Vector Laboratories), and
viewed using a Leica laser confocal microscope. Similarly, living
HEK293 cells, transfected with EGFP-tagged constructs and
seeded on coverslips coated with poly-D-lysine, were imaged using
a Leica laser confocal microscope equipped with a 633 water-
immersion objective.
HEK293 Cell-Surface Enzyme-Linked Immunosorbent Assay
At 24 hr posttransfection, cells from 6-well plates were split to
24-well plates coated with poly-D-lysine (Sigma) and cultured for
additional 12–16 hr before analysis. Colorimetric cell-surface ELISAs
were performed as described (Ratnam and Teichberg, 2005). Cells
were washed once with PBS, fixed for 10 min at RT with 4% parafor-
maldehyde in PBS, quenched with PBS containing 1% glycine for
10 min, and blocked for 1 hr in PBS containing 4% (w/v) skim milk
powder under nonpermeate and permeate (0.2% Triton X-100) con-
ditions. Cells were incubated for 1 hr at RT with primary antibodies
(anti-EGFP 1:2000; abcam, Cambridge, UK; or anti-HA 1:500; Roche,
Penzberg, Germany), washed three times for 5 min with 4% milk/
PBS, and then incubated for 1 hr at RT with the appropriate horse-
radish peroxidase-conjugated secondary antibodies (Jackson labo-
ratories, West grove, PA) in 4% milk/PBS. The cells were washed
with PBS and exposed to o-phenylenediamine substrate (Sigma)
in phosphate-citrate buffer, and the color was allowed to develop
for 10 min. The reaction was stopped by addition of 0.2 volume of
3 N HCl, and the color intensity was determined with a spectropho-
tometer at 492 nm.
Surface Protein Biotinylation of Xenopus Oocytes
Surface protein biotinylation was done as described previously
(Ayalon and Stern-Bach, 2001). Briefly, 20 oocytes expressing the in-dicated construct were incubated with 0.5 mg/ml EZ-link Sulfo-
NHS-SS-Biotin (Pierce, Rockford, IL) in NFR for 30 min at 17C.
Oocytes were washed five times with NFR and homogenized
through a p200 pipette tip in Buffer H containing 100 mM NaCl, 20
mM Tris-Cl, pH 7.4, 1% Triton X-100, and protease inhibitor cocktail
(Complete Protease Inhibitors, Roche) in a volume of 40 ml per
oocyte. Lysates were centrifuged at 14,000 3 g for 5 min. Cleared
lysate (50 ml) was reserved for whole-cell protein sample (total).
The remaining lysate was incubated with 50 ml of 50% streptavi-
din-Sepharose slurry (Pierce) for 3 hr at 4C. Beads were washed
five times in Buffer H, and biotinylated proteins were eluted by
5 min boiling in SDS-PAGE sample buffer. Total and biotinylated
(Bio) fractions were separated on SDS-PAGE (8%), and Western-
blot analysis using C-terminal anti-GluR6 antibodies was done as
described above.
Deglycosylation with Endoglycosidase H (Endo H)
and Peptide-N-Glycosidase F (PNGase)
Total protein extracts from HEK293 cells 36 hr posttransfection were
obtained by cell lysis in a buffer containing (mM): 10 HEPES (pH 7.4),
150 NaCl, 1% Triton X-100, and complete protease inhibitor mixture
(Roche), followed by centrifugation at 14,000 3 g for 15 min to re-
move the nuclear fraction. Whole-cell extracts from oocytes were
obtained as described above. In both cases, 20 mg of total protein
were digested with 2 ml of EndoH or PNGase (New England Biolabs)
for 2 hr at 37C following the manufacturer’s instructions. Proteins
were separated on SDS-PAGE (8%), blotted, and visualized with
anti-GluR6 antibodies as described above.
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